The Role of Cognitive-Behavioural Therapy for Patients with Depression in Parkinson's Disease
Depression is a common complication of Parkinson's disease (PD) with considerable impact on patients' quality of life. However, at present the most appropriate treatment approach is unclear. There are limited data on antidepressant medications in PD-associated depression (dPD) and those av...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2011-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.4061/2011/737523 |
id |
doaj-dd073ec3c2214791b7c2cf29d830cfeb |
---|---|
record_format |
Article |
spelling |
doaj-dd073ec3c2214791b7c2cf29d830cfeb2020-11-25T00:03:46ZengHindawi LimitedParkinson's Disease2042-00802011-01-01201110.4061/2011/737523737523The Role of Cognitive-Behavioural Therapy for Patients with Depression in Parkinson's DiseaseAndreas Charidimou0John Seamons1Caroline Selai2Anette Schrag3Institute of Neurology, The National Hospital for Neurology and Neurosurgery, University College London (UCL), Queen Square, London WC1N 3BG, UKInstitute of Neurology, The National Hospital for Neurology and Neurosurgery, University College London (UCL), Queen Square, London WC1N 3BG, UKInstitute of Neurology, The National Hospital for Neurology and Neurosurgery, University College London (UCL), Queen Square, London WC1N 3BG, UKDepartment of Clinical Neurosciences, Institute of Neurology, University College London, Royal Free Campus, London NW3 2PF, UKDepression is a common complication of Parkinson's disease (PD) with considerable impact on patients' quality of life. However, at present the most appropriate treatment approach is unclear. There are limited data on antidepressant medications in PD-associated depression (dPD) and those available suggest limited efficacy and tolerability of these drugs. Cognitive behavioural therapy (CBT) has been shown to be an effective treatment of depressive disorders. Treatment of dPD with CBT may pose particular challenges, including possible different pathophysiology, physical and mental comorbidities, and barriers to treatment through disability, which do not allow simple transfer of these results to patients with dPD. However, a number of case reports, case series, and small pilot studies suggest that this is a promising treatment for patients with PD. We here summarise the published evidence on this treatment in dPD.http://dx.doi.org/10.4061/2011/737523 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Andreas Charidimou John Seamons Caroline Selai Anette Schrag |
spellingShingle |
Andreas Charidimou John Seamons Caroline Selai Anette Schrag The Role of Cognitive-Behavioural Therapy for Patients with Depression in Parkinson's Disease Parkinson's Disease |
author_facet |
Andreas Charidimou John Seamons Caroline Selai Anette Schrag |
author_sort |
Andreas Charidimou |
title |
The Role of Cognitive-Behavioural Therapy for Patients with Depression in Parkinson's Disease |
title_short |
The Role of Cognitive-Behavioural Therapy for Patients with Depression in Parkinson's Disease |
title_full |
The Role of Cognitive-Behavioural Therapy for Patients with Depression in Parkinson's Disease |
title_fullStr |
The Role of Cognitive-Behavioural Therapy for Patients with Depression in Parkinson's Disease |
title_full_unstemmed |
The Role of Cognitive-Behavioural Therapy for Patients with Depression in Parkinson's Disease |
title_sort |
role of cognitive-behavioural therapy for patients with depression in parkinson's disease |
publisher |
Hindawi Limited |
series |
Parkinson's Disease |
issn |
2042-0080 |
publishDate |
2011-01-01 |
description |
Depression is a common complication of Parkinson's disease (PD) with considerable impact on patients' quality of life. However, at present the most appropriate treatment approach is unclear. There are limited data on antidepressant medications in PD-associated depression (dPD) and those available suggest limited efficacy and tolerability of these drugs. Cognitive behavioural therapy (CBT) has been shown to be an effective treatment of depressive disorders. Treatment of dPD with CBT may pose particular challenges, including possible different pathophysiology, physical and mental comorbidities, and barriers to treatment through disability, which do not allow simple transfer of these results to patients with dPD. However, a number of case reports, case series, and small pilot studies suggest that this is a promising treatment for patients with PD. We here summarise the published evidence on this treatment in dPD. |
url |
http://dx.doi.org/10.4061/2011/737523 |
work_keys_str_mv |
AT andreascharidimou theroleofcognitivebehaviouraltherapyforpatientswithdepressioninparkinsonsdisease AT johnseamons theroleofcognitivebehaviouraltherapyforpatientswithdepressioninparkinsonsdisease AT carolineselai theroleofcognitivebehaviouraltherapyforpatientswithdepressioninparkinsonsdisease AT anetteschrag theroleofcognitivebehaviouraltherapyforpatientswithdepressioninparkinsonsdisease AT andreascharidimou roleofcognitivebehaviouraltherapyforpatientswithdepressioninparkinsonsdisease AT johnseamons roleofcognitivebehaviouraltherapyforpatientswithdepressioninparkinsonsdisease AT carolineselai roleofcognitivebehaviouraltherapyforpatientswithdepressioninparkinsonsdisease AT anetteschrag roleofcognitivebehaviouraltherapyforpatientswithdepressioninparkinsonsdisease |
_version_ |
1725432117693775872 |